According to Yahoo!Finance, “Rennova Health, Inc., together with its subsidiaries, provides a suite of healthcare related products and services to healthcare providers in the United States. The company operates in three segments: Laboratory Services, Supportive Software Solutions, and Decision Support and Informatics Operations. It provides toxicology, clinical pharmacogenetics, and esoteric testing services. The company also offers Advantage, a HIPAA compliant software; Clinlab, a Windows-based Web-enabled laboratory information management system; and Medical Mime, a suite of solutions, which include an optimized Electronic health records (EHR) for substance abuse and behavioral health providers, a dictation-based ambulatory EHR for physician practices, and advanced transcription services. In addition, it develops and markets interpretation and decision support solutions that enhance cancer diagnoses and treatment through actionable data analytics and reporting for oncologists and their patients.”
Rennova Health traded from November 21, 2008 to January 2018 at –99% below the price of the peak established in 1995.
The Study of Failure
"The marvelous thing about the stock market is this--it's always there. Make a mistake, and you can call your broker and blow out that mistake in 30 seconds (try doing that in your own business). Miss a move, and it's just a matter of time before a second and a third and a fourth opportunity arrives. Sell too soon, and you can buy back in a few minutes. (Russell, Richard. Dow Theory Letters. May 15, 1991. page 3.)"